Skip to content
The Policy VaultThe Policy Vault

praziquantelCareFirst (Caremark)

Schistosomiasis due to all species of Schistosoma

Initial criteria

  • Infection confirmed by a diagnostic or laboratory test (e.g., imaging scans, scotch tape test, blood, stool, or urine test)
  • Patient age ≥ 1 year
  • Request is for praziquantel (Biltricide) for treatment of schistosomiasis, clonorchiasis, or opisthorchiasis for ANY of the following: a quantity up to 36 tablets, a second day or course of therapy (first course of therapy administered within the past year)

Approval duration

1 month